HEADER VIRAL PROTEIN 18-JAN-21 7DX4 TITLE THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANGIOTENSIN-CONVERTING ENZYME HOMOLOG,ACEH,ANGIOTENSIN- COMPND 5 CONVERTING ENZYME-RELATED CARBOXYPEPTIDASE,ACE-RELATED COMPND 6 CARBOXYPEPTIDASE,METALLOPROTEASE MPROT15; COMPND 7 EC: 3.4.17.23,3.4.17.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: E; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HEAVY CHAIN OF FC08 FAB; COMPND 15 CHAIN: H; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 4; COMPND 18 MOLECULE: LIGHT CHAIN OF FC08 FAB; COMPND 19 CHAIN: L; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 11 2; SOURCE 12 ORGANISM_COMMON: 2019-NCOV; SOURCE 13 ORGANISM_TAXID: 2697049; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 22 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 23 MOL_ID: 4; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 28 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS SARS-COV-2, SPIKE, NEUTRALIZING ANTIBODY, HACE2, RBD, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR L.CAO,X.WANG REVDAT 2 23-FEB-22 7DX4 1 JRNL REVDAT 1 21-APR-21 7DX4 0 JRNL AUTH L.ZHANG,L.CAO,X.S.GAO,B.Y.ZHENG,Y.Q.DENG,J.X.LI,R.FENG, JRNL AUTH 2 Q.BIAN,X.L.GUO,N.WANG,H.Y.QIU,L.WANG,Z.CUI,Q.YE,G.CHEN, JRNL AUTH 3 K.K.LU,Y.CHEN,Y.T.CHEN,H.X.PAN,J.YU,W.YAO,B.L.ZHU,J.CHEN, JRNL AUTH 4 Y.LIU,C.F.QIN,X.WANG,F.C.ZHU JRNL TITL A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE JRNL TITL 2 DESIGN AGAINST SARS-COV-2. JRNL REF NATL SCI REV V. 8 AB053 2021 JRNL REFN ESSN 2053-714X JRNL PMID 34676098 JRNL DOI 10.1093/NSR/NWAB053 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 87543 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7DX4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1300020366. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SEVERE ACUTE RESPIRATORY REMARK 245 SYNDROME CORONAVIRUS 2; REMARK 245 ANGIOTENSIN-CONVERTING ENZYME 2; REMARK 245 SPIKE PROTEIN S1; FC08 FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 C LEU H 4 OG SER H 26 0.77 REMARK 500 N LEU H 5 OG SER H 26 0.94 REMARK 500 CA LEU H 5 CB SER H 26 1.14 REMARK 500 O LEU H 4 OG SER H 26 1.39 REMARK 500 O THR H 29 NH2 ARG H 99 1.52 REMARK 500 N LEU H 5 CB SER H 26 1.68 REMARK 500 CA LEU H 5 OG SER H 26 1.86 REMARK 500 CB LEU H 5 CB SER H 26 1.98 REMARK 500 O PHE H 30 N SER H 32 2.09 REMARK 500 O LEU H 4 CB SER H 26 2.13 REMARK 500 C LEU H 4 CB SER H 26 2.14 REMARK 500 CA LEU H 4 OG SER H 26 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU E 441 CB - CG - CD2 ANGL. DEV. = -10.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 87 33.04 -98.82 REMARK 500 ASP A 509 64.46 60.13 REMARK 500 ASP E 428 49.95 -90.39 REMARK 500 SER E 438 44.91 -140.30 REMARK 500 ALA H 25 85.35 -44.04 REMARK 500 PHE H 30 -80.38 -128.01 REMARK 500 SER H 31 55.39 -52.53 REMARK 500 SER H 32 47.26 165.85 REMARK 500 TYR H 33 136.01 -170.57 REMARK 500 PRO H 54 43.85 -76.82 REMARK 500 GLU H 83 91.63 -67.21 REMARK 500 ARG H 88 -72.31 -64.56 REMARK 500 ALA H 108 -157.51 -149.51 REMARK 500 TYR H 111 -85.11 -78.88 REMARK 500 PHE H 112 -83.55 -135.40 REMARK 500 ASP H 113 -4.82 -146.74 REMARK 500 ASN L 28 -52.61 -120.23 REMARK 500 LEU L 49 -152.00 -88.34 REMARK 500 ASN L 53 -26.23 74.30 REMARK 500 SER L 54 93.64 -162.02 REMARK 500 ASN L 55 -179.95 -176.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE H 112 ASP H 113 127.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-30895 RELATED DB: EMDB REMARK 900 THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX DBREF 7DX4 A 19 615 UNP Q9BYF1 ACE2_HUMAN 19 615 DBREF 7DX4 E 333 526 UNP P0DTC2 SPIKE_SARS2 333 526 DBREF 7DX4 H 3 126 PDB 7DX4 7DX4 3 126 DBREF 7DX4 L 2 113 PDB 7DX4 7DX4 2 113 SEQRES 1 A 597 SER THR ILE GLU GLU GLN ALA LYS THR PHE LEU ASP LYS SEQRES 2 A 597 PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SER SER SEQRES 3 A 597 LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 A 597 ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS TRP SER SEQRES 5 A 597 ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN MET TYR SEQRES 6 A 597 PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS LEU GLN SEQRES 7 A 597 LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL LEU SER SEQRES 8 A 597 GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU ASN THR SEQRES 9 A 597 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN PRO SEQRES 10 A 597 ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO GLY LEU SEQRES 11 A 597 ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN GLU ARG SEQRES 12 A 597 LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL GLY LYS SEQRES 13 A 597 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 A 597 ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP TYR GLY SEQRES 15 A 597 ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY VAL ASP SEQRES 16 A 597 GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU ASP VAL SEQRES 17 A 597 GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR GLU HIS SEQRES 18 A 597 LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN ALA TYR SEQRES 19 A 597 PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO ALA HIS SEQRES 20 A 597 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 A 597 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 A 597 ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP ASP ALA SEQRES 23 A 597 GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 A 597 VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 A 597 SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS ALA VAL SEQRES 26 A 597 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 A 597 ARG ILE LEU MET CYS THR LYS VAL THR MET ASP ASP PHE SEQRES 28 A 597 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 A 597 MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 A 597 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 A 597 SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SER ILE SEQRES 32 A 597 GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN GLU THR SEQRES 33 A 597 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 A 597 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 A 597 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP GLN TRP SEQRES 36 A 597 MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 A 597 VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 A 597 PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SER PHE SEQRES 39 A 597 ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE GLN PHE SEQRES 40 A 597 GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU GLY PRO SEQRES 41 A 597 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 A 597 GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SER GLU SEQRES 43 A 597 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 A 597 ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 A 597 LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SER PHE SEQRES 46 A 597 VAL GLY TRP SER THR ASP TRP SER PRO TYR ALA ASP SEQRES 1 E 194 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 E 194 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 E 194 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 E 194 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 E 194 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 E 194 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 E 194 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 E 194 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 E 194 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 E 194 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 E 194 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 E 194 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 E 194 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN SEQRES 14 E 194 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 E 194 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 1 H 124 GLN LEU LEU GLN GLN SER GLY ALA GLU VAL LYS LYS PRO SEQRES 2 H 124 GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY GLY SEQRES 3 H 124 THR PHE SER SER TYR ALA ILE SER TRP VAL ARG GLN ALA SEQRES 4 H 124 PRO GLY GLN GLY LEU GLU TRP MET GLY GLY ILE ILE PRO SEQRES 5 H 124 ILE ILE GLY ILE ALA ASN TYR ALA GLN LYS PHE GLN GLY SEQRES 6 H 124 ARG VAL THR ILE THR ALA ASP LYS SER THR SER THR ALA SEQRES 7 H 124 TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR ALA SEQRES 8 H 124 VAL TYR TYR CYS ALA ARG GLU ARG GLY TYR SER GLY TYR SEQRES 9 H 124 GLY ALA ALA TYR TYR PHE ASP TYR TRP GLY GLN GLY THR SEQRES 10 H 124 LEU VAL THR VAL SER SER ALA SEQRES 1 L 112 SER VAL LEU THR GLN PRO PRO SER VAL SER GLY ALA PRO SEQRES 2 L 112 GLY GLN ARG VAL THR ILE SER CYS THR GLY SER SER SER SEQRES 3 L 112 ASN ILE GLY ALA GLY TYR ASP VAL HIS TRP TYR GLN GLN SEQRES 4 L 112 LEU PRO GLY THR ALA PRO LYS LEU LEU ILE TYR GLY ASN SEQRES 5 L 112 SER ASN ARG PRO SER GLY VAL PRO ASP ARG PHE SER GLY SEQRES 6 L 112 SER LYS SER GLY THR SER ALA SER LEU ALA ILE THR GLY SEQRES 7 L 112 LEU GLN ALA GLU ASP GLU ALA ASP TYR TYR CYS GLN SER SEQRES 8 L 112 TYR ASP SER SER LEU SER GLY SER VAL PHE GLY GLY GLY SEQRES 9 L 112 THR LYS LEU THR VAL LEU GLY GLN HET NAG A 701 14 HET NAG A 702 14 HET NAG A 703 14 HET NAG A 704 14 HET NAG E 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 5(C8 H15 N O6) HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 THR A 55 GLN A 81 1 27 HELIX 3 AA3 PRO A 84 ILE A 88 5 5 HELIX 4 AA4 ASN A 90 GLN A 101 1 12 HELIX 5 AA5 ASN A 103 LEU A 108 5 6 HELIX 6 AA6 SER A 109 THR A 129 1 21 HELIX 7 AA7 PRO A 146 SER A 155 1 10 HELIX 8 AA8 ASP A 157 GLU A 171 1 15 HELIX 9 AA9 GLU A 171 ALA A 193 1 23 HELIX 10 AB1 TYR A 199 ARG A 204 1 6 HELIX 11 AB2 GLY A 205 TYR A 207 5 3 HELIX 12 AB3 GLY A 220 GLU A 231 1 12 HELIX 13 AB4 ILE A 233 TYR A 252 1 20 HELIX 14 AB5 HIS A 265 LEU A 267 5 3 HELIX 15 AB6 TRP A 275 TYR A 279 5 5 HELIX 16 AB7 VAL A 293 GLN A 300 1 8 HELIX 17 AB8 ASP A 303 VAL A 318 1 16 HELIX 18 AB9 THR A 324 SER A 331 1 8 HELIX 19 AC1 MET A 366 TYR A 385 1 20 HELIX 20 AC2 PRO A 389 ARG A 393 5 5 HELIX 21 AC3 PHE A 400 SER A 411 1 12 HELIX 22 AC4 THR A 414 ILE A 421 1 8 HELIX 23 AC5 ASP A 431 ILE A 446 1 16 HELIX 24 AC6 GLY A 448 LYS A 465 1 18 HELIX 25 AC7 PRO A 469 ASP A 471 5 3 HELIX 26 AC8 GLN A 472 ILE A 484 1 13 HELIX 27 AC9 CYS A 498 SER A 502 5 5 HELIX 28 AD1 LEU A 503 ASN A 508 1 6 HELIX 29 AD2 PHE A 512 TYR A 515 5 4 HELIX 30 AD3 TYR A 516 GLN A 531 1 16 HELIX 31 AD4 PRO A 538 CYS A 542 5 5 HELIX 32 AD5 SER A 547 ARG A 559 1 13 HELIX 33 AD6 PRO A 565 GLY A 575 1 11 HELIX 34 AD7 VAL A 581 PHE A 588 1 8 HELIX 35 AD8 PHE A 588 ASN A 599 1 12 HELIX 36 AD9 LYS A 600 SER A 602 5 3 HELIX 37 AE1 PHE E 338 ASN E 343 1 6 HELIX 38 AE2 TYR E 365 ASN E 370 1 6 HELIX 39 AE3 THR E 385 LEU E 390 5 6 HELIX 40 AE4 GLY E 404 ARG E 408 5 5 HELIX 41 AE5 SER E 438 SER E 443 1 6 HELIX 42 AE6 GLY E 502 GLN E 506 5 5 HELIX 43 AE7 GLN L 81 GLU L 85 5 5 SHEET 1 AA1 2 VAL A 132 CYS A 133 0 SHEET 2 AA1 2 CYS A 141 LEU A 142 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 ASP A 350 0 SHEET 2 AA3 2 PHE A 356 LEU A 359 -1 O ARG A 357 N TRP A 349 SHEET 1 AA4 5 ASN E 354 ILE E 358 0 SHEET 2 AA4 5 ASN E 394 ILE E 402 -1 O VAL E 395 N ILE E 358 SHEET 3 AA4 5 TYR E 508 GLU E 516 -1 O VAL E 512 N ASP E 398 SHEET 4 AA4 5 CYS E 432 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 5 AA4 5 THR E 376 CYS E 379 -1 N LYS E 378 O VAL E 433 SHEET 1 AA5 2 CYS E 361 VAL E 362 0 SHEET 2 AA5 2 VAL E 524 CYS E 525 1 O CYS E 525 N CYS E 361 SHEET 1 AA6 2 LEU E 452 ARG E 454 0 SHEET 2 AA6 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SHEET 1 AA7 2 TYR E 473 GLN E 474 0 SHEET 2 AA7 2 CYS E 488 TYR E 489 -1 O TYR E 489 N TYR E 473 SHEET 1 AA8 4 GLN H 6 GLN H 7 0 SHEET 2 AA8 4 VAL H 19 LYS H 24 -1 O LYS H 24 N GLN H 6 SHEET 3 AA8 4 THR H 79 LEU H 84 -1 O ALA H 80 N CYS H 23 SHEET 4 AA8 4 THR H 70 ASP H 74 -1 N THR H 72 O TYR H 81 SHEET 1 AA9 6 GLU H 11 LYS H 13 0 SHEET 2 AA9 6 THR H 119 VAL H 123 1 O THR H 122 N LYS H 13 SHEET 3 AA9 6 ALA H 93 TYR H 96 -1 N TYR H 95 O THR H 119 SHEET 4 AA9 6 ILE H 35 GLN H 40 -1 N GLN H 40 O VAL H 94 SHEET 5 AA9 6 LEU H 46 ILE H 52 -1 O GLU H 47 N ARG H 39 SHEET 6 AA9 6 ALA H 59 TYR H 61 -1 O ASN H 60 N GLY H 51 SHEET 1 AB1 5 SER L 9 GLY L 12 0 SHEET 2 AB1 5 THR L 106 VAL L 110 1 O LYS L 107 N VAL L 10 SHEET 3 AB1 5 ASP L 87 ASP L 94 -1 N TYR L 88 O THR L 106 SHEET 4 AB1 5 VAL L 35 GLN L 40 -1 N HIS L 36 O GLN L 91 SHEET 5 AB1 5 LYS L 47 LEU L 48 -1 O LYS L 47 N GLN L 39 SHEET 1 AB2 4 SER L 9 GLY L 12 0 SHEET 2 AB2 4 THR L 106 VAL L 110 1 O LYS L 107 N VAL L 10 SHEET 3 AB2 4 ASP L 87 ASP L 94 -1 N TYR L 88 O THR L 106 SHEET 4 AB2 4 GLY L 99 VAL L 101 -1 O VAL L 101 N SER L 92 SHEET 1 AB3 3 ARG L 17 SER L 21 0 SHEET 2 AB3 3 SER L 74 THR L 78 -1 O ILE L 77 N VAL L 18 SHEET 3 AB3 3 PHE L 64 SER L 67 -1 N SER L 65 O ALA L 76 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.03 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 4 CYS E 336 CYS E 361 1555 1555 2.03 SSBOND 5 CYS E 379 CYS E 432 1555 1555 2.04 SSBOND 6 CYS E 391 CYS E 525 1555 1555 2.03 SSBOND 7 CYS E 480 CYS E 488 1555 1555 2.02 SSBOND 8 CYS H 23 CYS H 97 1555 1555 2.02 SSBOND 9 CYS L 22 CYS L 90 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 704 1555 1555 1.43 LINK ND2 ASN A 90 C1 NAG A 702 1555 1555 1.44 LINK ND2 ASN A 322 C1 NAG A 703 1555 1555 1.44 LINK ND2 ASN A 546 C1 NAG A 701 1555 1555 1.43 LINK ND2 ASN E 343 C1 NAG E 601 1555 1555 1.45 CISPEP 1 GLU A 145 PRO A 146 0 -7.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000